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ABSTRACT
The use of probiotics, prebiotics and antioxidants could be found beneficial for dogs with
chronic kidney disease (CKD). The aim of our case-control study is to evaluate the synergistic
effect of a diet integrated with a supplement containing probiotics (Lactobacillus acidophilus),
prebiotics (fructoligosaccharides) and antioxidants (Olea Europaea extract) on the nutritional sta-
tus and on serum and urinary parameters of dogs with CKD. A total of 30 dogs classified with
IRIS CKD stage 3 were enrolled and randomly assigned to a control (CG, n¼ 15) and a treated
(TG n¼ 15) group. The trial consisted in a 7-days adaptation period, followed by 90days where
animals in the TR group received the supplement, while in the CG group the placebo. No signifi-
cant changes in body weight and body condition score were recorded. We recorded a signifi-
cant improvement of the protein plasmatic level and a decrease in blood phosphorus, systolic
pressure, BUN, proteinuria and urine protein-to-creatinine ratio throughout the trial in the TG
compared to the CG group. Furthermore, the parameters related to inflammation and oxidative
stress (C-reactive protein and Reactive Oxygen Metabolite- derived compound, respectively)
were lower in the TG than in the CG group throughout the study. Our results showed that the
supplement allows to maintain the correct nutritional status and to improve blood and kidney
parameters in dogs with advance stage of CKD. This supplement could be considered as a new
nutritional approach for treating this condition.
HIGHLIGHTS
 Diet supplemented with prebiotics, probiotics and antioxidants is safe for dogs with CKD.
 The synergic effect of prebiotics, probiotics and antioxidants included in the supplement
under study shows the maintenance of a good nutritional status and the improvement of
blood and urinary parameters in dogs with CKD.
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Chronic kidney disease (CKD) is a chronic degenerative
disease frequently occurring in dogs (Bartges 2012).
Diagnosis of CKD is made through the anamnesis
(age, breed, sex, diet, and pharmacological therapy),
clinical signs (polyuria, polydipsia, weight loss,
decreased appetite, ulcers, dehydration, hypertension,
lethargy) and laboratory findings (blood cytometric
examination, serum and urinary biochemical profile
and renal morphology) (Relford et al. 2016). Data
obtained from animals must be then interpreted using
the International Renal Interest Society (De Loor et al.
2013). Scientific studies have been highlighted an
abnormal composition of the microbiota in CKD
patients (Vanholder and Glorieux 2015). In fact, it has
been shown that also animals affected by the disease
have an increase in bacterial species subject to proteo-
lytic fermentation, such as Clostridium and Bacteroides
and a decrease in Lactobacilli and Bifidobacteria (Nallu
et al. 2017). Moreover, occurring inflammation and oxi-
dative stress have a significant detrimental effect on
renal function (Irazabal and Torres 2020). The use of
ingredients in the diet that have an effect directly on
the renal function or through a secondary product
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mediated by the microbiome can be beneficial for
patients with renal disease. Therefore, in order to
maintain a correct balance of the gastrointestinal
microbiota, the use of probiotics, prebiotics and anti-
oxidants has increased in humans as well as in animals
(Rose et al. 2017; Fusi et al. 2019; Bruni et al. 2020;
Saettone et al. 2020). Lactobacillus and Bifidobacterium
are the most widely used probiotics in veterinary
medicine. In fact, it has been shown that Lactobacillus
acidophilus stabilises the microbiota and strengthens
the gastrointestinal barrier in dogs and cats by limit-
ing the adhesion of pathogens. Prebiotic fibres (such
as fructooligosaccharides) are a source of nutrition for
probiotics and contribute to the beneficial bacterial
proliferation of the colon by reducing intestinal inflam-
mation and increasing the absorption of nutrients
(Hall et al. 2016). In addition, scientific studies indicate
that a diet supplemented with specific antioxidants
(e.g. European Olea, Vitamin E, carotenoids, polyphe-
nols, flavonoids) is important for limiting renal oxida-
tive stress and the progression of CKD (Halfen et
al. 2020).
The purpose of our study was to evaluate the syn-
ergistic effect of probiotics (L. acidophilus), prebiotics
(fructoligosaccharides) and antioxidants (Olea
Europaea extract), administered as a sole food supple-
ment on the nutritional status and on serum and urin-
ary parameters in dogs with CKD.
Materials and methods
Animals and study design
A group of 30 medium-sized adult owned dogs (age>
1 year) was included in the study. All dogs were diag-
nosed with IRIS CKD stage 3, following a four-stage
scale of disease progression according to the
International Renal Interest Society (IRIS) guidelines.
These dogs were enrolled by the Napolivet Veterinary
Clinic in Naples (Italy) and randomly assigned to two
groups. Fifteen dogs (n¼ 15, 5 males, 10 females),
were supplemented with the complementary feed
under study (TG group) and the other (n¼ 15, 5 males
and 10 females) with a placebo (CG group). Dogs with
concomitant diseases (acute kidney injury, pre-renal or
post-renal azotaemia, genitourinary tract inflammation
or infection, urinary tract obstruction, chronic heart
disease, neoplasia, hypothyroidism, diabetes) have
been excluded from the study.
Supplement and diet
During the entire duration of the trial (90 days), and
the 7 days of adaptation, both CG and TG dogs
received a complete dry commercial diet (Royal Canin
– Renal canine) twice daily. The quantity of food
offered was calculated on the basis of the estimated
needs according to the NRC guidelines (Council NR
2006). The same diet was maintained throughout the
entire study period in both groups. The TG group
received the supplement (Renal N, Candioli s.r.l., Italy)
for 90 days. It contains L. acidophilus D2/CSL (30mg/
day) (Bruni et al. 2020), fructooligosaccharides
(400mg/day) and Olea Europaea extract (40mg/day)
(Supplementary Appendix 1) . The CG received the
placebo for the same period of time (Supplementary
Appendix 1).
Analysis
Body weight (BW) and Body Condition Score (BCS)
were recorded at the baseline T0 (day 0), then at T30
(day 30), T60 (day 60) and T90 (day 90). The BW (kg)
was measured always using the same scale (pet scale,
four sensors, maximum 100 kg, d1=4100 g; Momert,
Duna_ujv_aros, Hungary) and at the same time of the
day. BCS is an effective assessment of body fat and it
is evaluated through the visual examination and pal-
pation of the animal. Scores from 1 to 9 were assigned
by the same trained veterinarian who performed the
BW measurement, a score of 4 or 5 represents the
ideal (FEDIAF 2020). Measurements were made simul-
taneously with the BW, thus avoiding excessive han-
dling of animals. At the beginning and at the end of
each visit, the blood pressure (BP) was measured by
an indirect Doppler method using the radial pulse,
with the dog in left lateral decubitus. During the
examination, five measurements were taken and the
average value recorded (WGng Vet USA Digital Blood
Pressure NIBP). Blood samples were obtained by punc-
ture of the jugular vein during each of the four sched-
uled veterinary cheques. The haematochemical and
biochemical parameters were measured by using an
haematology analyser (scil Vet abc Plus) according to
the instructions of the manufacturer. Blood cell sub-
groups were quantified using flow cytometry. The
hematochemical parameters measured were: haemato-
crit (HCT), haemoglobin (HG), red blood cells (RBC),
white blood cells (WBC), neutrophil (N), eosinophil
(EO), lymphocytes (LYM), basophiles (BA), platelets
(PLTS). The biochemical parameters measured were:
blood urea nitrogen (BUN), creatinine (CREA), phos-
phorus (P), total protein (TP), albumin (ALB), albumin/
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globulin (A/G), glucose (GLU), alanine aminotransferase
(ALT), aspartate aminotransferase (AST), alkaline phos-
phatase (ALP), bilirubin (BIL), cholesterol (CHOL), and
the symmetric dimethylarginine (SDMA).
Venous blood gas analysis was performed immedi-
ately after blood collection with a standard analytical
device in order to evaluate the ionised calcium (iCA)
(An et al. 2013).
An ELISA test for dogs (Tridelta Development
Limited) was performed for the analysis of C-reactive
protein (CRP) (Kjelgaard-Hansen et al. 2003), while the
Reactive Oxygen Metabolite- derived compound (d-
ROMs) analysis was carried out using a Free-Diacron
international SRL automatic analyser (Alberti et
al. 2000).
Urine samples were obtained by cystocentesis with
a 5ml syringe. A sterile collection tube was inserted
and analysed. Then, the samples were centrifuged
(2min at 1500  g), the supernatant removed and
stored at þ 4 C, so the urine sediment was obtained.
The examination of the urinary sediments and the
specific weight was performed by refractometry
(Aution Micro) .
The urinary protein concentration (UP) (mg/dl)
(pyrogallol red method) and the creatinine concentra-
tion (mg/dl) (Jaffe method) were evaluated in the
urine within 12 hours of collection. The urine protein-
to-creatinine ratio (UPC) was then calculated.
Statistical analysis
The variability of each parameter recorded over time
was analysed using PROC MIXED of SAS (SAS
9.4 2013).
The statistical model was built as the following:
yijn ¼ lþ Gi þ Aj þ GAij þ eijn
where:
 yijn¼ dependent variable (BP, BW, BCS, HCT, HB,
RBC, WBC, PLTS,BUN, CREA, P, TP, GLU, AST, ALP,
BIL, iCA, UP, UPC, CRP, d-ROMs, SDMA.
 l ¼ overall mean;
 Gi ¼ fixed effect of the ith group (j¼ 1, 2: con-
trol, treatment);
 Tj þ¼ fixed effect of the jth recording time (j¼ 1,
7: 0, 30, 60, 90 days)
 GTij ¼ fixed effect of the interaction between the
ith group and jth time
 eijn ¼ error.
Time was treated as a repeated measure and dog
within groups as repeated subject. The auto-regressive
covariance structure was used. Least square (LS)
means were separated by pair-wise t-test using PDIFF
option in SASVR with the Tukey adjustment for multiple
comparisons. Significance was set at 5% level.
Results and discussion
In the present study, we combined three types of
ingredients: prebiotics (Fructoligosaccharides), probiot-
ics (L. acidophilus D2/CSL) and antioxidants (Olea
Europea extract) in a single supplement to evaluate
their synergic effect on the nutritional status and on
serological and urinary parameters in dogs with
advanced CKD.
Several researchers have studied the effectiveness
of the dietary use of probiotics (living microorgan-
isms), prebiotics (non-digestible food ingredients) and
antioxidants on the balance and well-being of the
microbiota in subjects with kidney diseases (Swanson
et al. 2002; Fernandez-Prado et al. 2017; Koh and
Rowling 2017). For example, L. acidophilus is a pro-
biotic capable of modifying the intestinal microbiota
and influencing the enteric inflammatory condition
((Mutsaers et al. 2013).
All dogs were in a stable condition during the
whole study period and no gastro-enteric symptoms
(i.e. vomiting, diarrhea) were recorded confirming the
safety and tolerability of the product. No changes in
the feed administration/consumption have been regis-
tered. No significant difference in BW and BCS in the
two groups was found for the entire study period
(Supplementary Appendix 2), thus indicating good
maintenance of the nutritional conditions (value close
to 5 on a BCS 1–9 scale).
We have observed an improvement in the blood
and urinary parameters normally used by veterinarians
to monitor the progress of the kidney disease
(Wilkinson and McEwan 1991). Regarding blood count
values and liver parameters (Supplementary Appendix
2), the two groups of dogs did not statistically differ,
thus indicating a low probability of infection during
the study and no damage of the liver function due to
the supplementation further underlying the safety of
the product.
The effects of adding the studied supplement on
blood pressure, blood parameters and urinary bio-
chemical profile are shown in Supplementary
Appendix 2. Blood pressure at T30, T60 and T90 was
significantly lower in the TG group than in the CG
group (p< .01). We noticed that both groups were
slightly hypertensive (<150mmHg) at the time of the
enrolment, but the TG group shows significant lower
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blood pressure values from T30 on. Systemic hyper-
tension is common in canine and feline CKD; reactive
oxygen species (ROS) are believed to contribute to the
increase in systemic blood pressure in CKD, therefore
the antioxidants contained in the supplement, Olea
Europaea extract, are able to reduce hypertension
(Susalit et al. 2011).
Serum creatinine did not differ between groups at
all times considered. This could be the result of a too
short supplement administration time and then it
would be difficult to see a significant improvement of
this parameter.
SDMA remained stable and there was no difference
between groups at different time intervals. It is used
as a biomarker of the decline in kidney function. It has
been shown that circulating levels of SDMA increase
in dogs and cats with renal insufficiency (Hall et al.
2015; El-Khoury et al. 2016). In our study, SDMA tends
to decrease in the TG group but the differences do
not reach significance even at the end of the study
(p¼ .07), indicating that the renal damage is present
but not in an advanced stage yet (Hall et al. 2016).
On the other hand, BUN was significantly lower in
the TG group than in the CG group at T30, T60 and
T90 (p< .01). BUN value is an important marker of
renal failure as it represents the concentration of non-
protein nitrogenous compounds (i.e. urea) in the
blood. High level of azotaemia in the blood, as
described by Krawiec (1996), can cause a range of clin-
ical symptoms in dogs such as loss of appetite, nau-
sea, vomiting, anorexia and gastrointestinal
disturbances (Krawiec 1996). Interestingly, in our study
the BUN values decreased in the TG group compared
to the CG group. This result confirms the efficacy of
the supplement, especially the prebiotic and probiotic
components, in reducing the intestinal absorption of
nitrogen waste derived from protein catabolism.
Regarding the urinalysis (Supplementary Appendix 2),
we registered several significant changes at T90 when
the UP was significantly lower in the TG group than in
the CG group (p< .01). The UPC was significantly
lower in the TG group compared to the CG group at
T30, T60 and T90 (p< .01). Similarly, the UPC was sig-
nificantly lower in the TG group from T30 on. These
results show an improvement in the kidney function
of the subjects in the TR group.
The hepatic parameters (AST, ALP, BIL) are shown
in Supplementary Appendix 2 and no significant differ-
ences (p> .05) between the two groups in the time
period considered were found.
Regarding CRP and d-ROMs (Supplementary
Appendix 2), at the end of the study (T90) the CRP
was significantly lower (p< .01) in the TG group than
in the CG group. Circulating bacterial DNA, derived
from the gut due to increased intestinal permeability
was detected in patients with CKD and correlated with
an increase in plasma CRP (Stenvinkel 2005). Our study
shows that dogs that received supplementation (TG)
have a significant reduction (p< .01) in the oxidative
stress parameter (d-ROMs) value compared to the CG
group from T30.
The data confirms some previous observations
made by Bulger and colleagues (Bulger et al. 1979)
according to which probiotics, prebiotics and antioxi-
dants are able to reduce inflammation and to influ-
ence the renal function through the mediation of the
microbiome. In dogs, dietary antioxidant supplementa-
tion has been found associated with improved renal
function (Brown 2008). Recently, the Olea Europaea
extract has been studied because of its antioxidant
benefits mainly due to the high number of phenolic
compounds present in the olive tree. Olive leaves con-
tain phenolic compounds (oleuropein, hydroxytyrosol,
verbascoside, apyx-nin-7-glucoside and luteolin-7-glu-
coside) with antioxidant, antihypertensive, hypogly-
caemic and hypocholesterolemic effects (Halfen et al.
2020). In our study, these antioxidants may have
reduced the blood values of d-ROMs related to oxida-
tive stress.
Regarding the haematological parameters
(Supplementary Appendix 2), we found higher values
for serum proteins (TP) at T60 and T90 in the TG
group compared to the CG group; this result is very
relevant because animals with CKD in poor nutritional
condition have a shorter survival (Rudinsky et al.
2018). Thus, a good nutritional management is very
important to ensure a long-term prognosis for sick
animals and to avoid the occurrence of cachexia or
sarcopenia (Freeman 2012).
P was higher in the TG group than in CT group at
T60 and T90 (p< .01). We found a significant reduction
in blood phosphorus in the TG group compared to
the CG group at T60 and T90, this is an interesting
result but of difficult interpretation based on the fact
that no effect on P was expected given the type of
supplement administered. As the kidney play a crucial
role in maintaining P balance, the significant reduction
in blood P in the TG group may be due to an
improvement of the kidney condition. In dogs with
renal insufficiency the P is not eliminated via the urine
and its level in the blood is higher than in
healthy dogs.
GLU and iCA remained stable in the two groups
through the study period, therefore the subjects under
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study do not present any disturbance in sugar and cal-
cium metabolism.
Conclusion
Our study shows that the use of probiotics, prebiotics
and antioxidants allows to maintain a good nutritional
status and to improve blood and urinary parameters
in dogs with advanced CKD. The administration of our
supplement could be considered a new nutritional
approach for the management of canine CKD. Further
studies conducted for a longer period of time and on
a larger group of dogs would be beneficial to strength
our findings. Further laboratory tests, such as micro-
biota evaluation, faecal nitrogen dosage or other
metabolites of bacterial metabolism would be useful
to better understand the effect of the supplement on
intestinal balance and consequently its influence on
the kidney disease.
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